Virus Testing Kits Market to Grow with a CAGR of 5.29% through 2030
Growing
prevalence of infectious diseases and rising awareness regarding early
diagnosis is expected to drive the Global Virus Testing Kits Market growth in
the forecast period, 2026-2030.
According
to TechSci Research report, “Virus Testing Kits Market – Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2030”, Global Virus Testing Kits Market stood at USD 16.57 Billion
in 2024 and is anticipated to project robust growth in the forecast period with
a CAGR of 5.29% through 2030. The increasing prevalence of infectious diseases
and the growing number of outbreaks are key drivers for the global virus test
kits sales market. Moreover, the rising demand for point-of-care (POC) testing
and home-based self-testing is fueling market growth. Furthermore, government
initiatives to promote awareness about early disease detection and treatment
are expected to generate lucrative opportunities for market players in the
forecast period.
Due
to the constant evolution of viruses and the ongoing detection of new
illnesses, there is a significant demand for diagnostic tests for viruses. For
instance, the recently identified coronavirus causes a respiratory illness with
symptoms appearing between 2 to 14 days after infection. Moreover, these
symptoms resemble those of a common cold, making early detection challenging.
As per the data from the Centers for Disease Control and Prevention, there were
330,891 cases of COVID-19 in the US as of April 6, 2021, resulting in 8,910
fatalities. Research facilities worldwide are currently developing novel viral
testing diagnostic kits capable of detecting the new coronavirus. This is
anticipated to drive substantial growth in the market for viral testing
diagnostic kits. Furthermore, the increasing prevalence of viral infections,
advancements in molecular diagnostics, and clinical research are among the key
factors propelling the global viral illness diagnosis market. The development
of precise rapid screening tests with improved detection time, along with the
availability of effective therapies, is driving market progress. Additionally,
the introduction of new quick diagnostic test kits, facilitated by innovative
approaches and recent breakthroughs in viral testing procedures, is expected to
further boost the growth of the global viral diagnostic test kits market during
the forecast period.
Robust
testing strategies are widely recognized as a crucial element in preparedness
and response to the COVID-19 pandemic. They facilitate early detection of
infection rates and transmission, among other factors. Many countries have
implemented mass testing strategies to mitigate the spread of infections.
Airports have conducted tests on individuals arriving from other countries,
while domestic travel has required COVID-19 certificates. Rapid test kits have
also been deployed to test individuals on-site, aiming to curb the transmission
of infections. Notably, numerous NGOs, regulatory bodies, and companies have
capitalized on the market opportunity by manufacturing COVID-19 test kits. This
increased investment has led to a significant boost in production volume,
thereby expanding the availability of rapid testing for COVID-19 and other
viral diseases in the market.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Virus Testing Kits Market.”
The
Global Virus Testing Kits Market is segmented into test type, application, end
user, regional distribution, and company.
Based on application, the hepatitis application segment is experiencing the fastest growth, outpacing other categories such as HIV, influenza, measles, and COVID-19. This robust expansion is primarily driven by the global health burden posed by various forms of hepatitis—particularly Hepatitis B (HBV) and Hepatitis C (HCV). According to Verified Market Reports, over 296 million people worldwide live with chronic HBV infections, while approximately 71 million are affected by HCV. This high prevalence has created a sustained demand for efficient diagnostic solutions, especially in low- and middle-income countries. Technological advancements have further propelled the growth of hepatitis testing kits. The emergence of rapid diagnostic tests, point-of-care assays, and self-testing kits has significantly improved accessibility and turnaround times for results.
Based on region, Based on regional analysis, the Asia-Pacific region is demonstrating the fastest growth in the virus testing kits market. This surge is primarily driven by a combination of high disease prevalence, expanding healthcare infrastructure, and increased government initiatives aimed at early diagnosis and disease prevention. Countries like China, India, Japan, South Korea, and several Southeast Asian nations are at the forefront of this growth, owing to their large populations and heightened focus on improving diagnostic capabilities. One of the key factors contributing to the rapid growth in Asia-Pacific is the region’s disproportionate burden of viral infections, particularly hepatitis. A significant percentage of global hepatitis B and C cases are concentrated in this region, creating an urgent need for accurate and accessible testing solutions. In response, governments across the region have implemented nationwide screening programs and awareness campaigns to curb the spread of these infections. These efforts are further supported by non-governmental organizations and international health agencies, which are working collaboratively to improve access to testing in underserved and rural areas.
Major
companies operating in Global Virus Testing Kits Market
are:
- Qiagen N.V.
- Abbott Laboratories Inc
- Thermo Fisher Scientific Inc
- Becton, Dickinson and Company
- BioMérieux SA
- Quidel Corporation
- .Rapikit
- Zoetis Inc
- Luminex Corporation
- F. Hoffmann-La Roche Ltd
Download
Free Sample Report
Customers can also request for 10% free
customization on this report.
“The virus testing kit is a diagnostic
tool used to detect antibodies in infected individuals. Various testing
methods, such as DFA, agglutinating testing, PCR, and solid-stage testing, are
employed. The technology platform, including enzyme-assisted nano complexes for
visual identification of nucleic acids, can be designed to detect a wide range
of diseases. Additionally, it aids in controlling emerging infectious diseases
and high-prevalence infections. These kits are based on techniques commonly
used in virology laboratories for detecting virus antibodies through tests like
rapid antigen testing, serology, or molecular diagnostics. The market growth is
driven by the rise in rapid and point-of-care testing, increasing prevalence of
virus-based diseases, and a higher rate of early diagnosis. Companies are
investing significantly in research and development activities for novel viral
testing kits. Furthermore, the COVID-19 pandemic has substantially contributed
to the exponential boost in the market. These factors collectively contribute
to the global development of virus test kits and drive market growth”, said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Virus Testing Kits
Market Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (DFA Tests,
Lateral Flow Tests, RT-PCR, Agglutination Assays, Solid-Phase Assays, Others), By
Application (Influenza, Hepatitis, HIV, Measles/Rubella, Rotavirus, Others), By
End User (Hospitals & Clinics, Diagnostic Centers & Laboratories,
Academic & Research Institutions, Others), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global Virus Testing Kits Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Virus Testing Kits Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com